Greenwich Lifesciences Inc (GLSI)
EBITDA Growth
1.89%
Quarterly · Period ending:
GLSI EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported1.89%period ending
Latest reported1.89%period ending
GLSI Quarterly EBITDA YoY % (78.42% → 1.89%)
Year-over-year change
High-resolution chart · PNG
GLSI ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 1.8928% | |
| -106.1731% | |
| 1.4502% | |
| -55.6275% | |
| -54.4414% | |
| -10.9852% | |
| -192.7821% | |
| -11.5825% | |
| -60.1123% | |
| -16.398% | |
| 1.5691% | |
| -3.139% | |
| -118.4025% | |
| -7.887% | |
| -18.2137% | |
| -168.8565% | |
| 0.4904% | |
| -228.2833% | |
| -105.0299% | |
| -236.8527% | |
| -257.393% | |
| -146.0431% | |
| -242.9197% | |
| 23.6187% | |
| 91.9509% | |
| -64.879% | |
| 78.4154% |